Source: International Congress 2018 – Diagnosis, prognostication and treatment of pulmonary embolism
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Erol (Ankara, Turkey), H. Hasanzade (Ankara, Turkey), F. Ciftci (Ankara, Turkey), A. Dastan (Ankara, Turkey), A. Ciledag (Ankara, Turkey), B. Eris Gulbay (Ankara, Turkey), A. Kaya (Ankara, Turkey), G. Celik (Ankara, Turkey), T. Acican (Ankara, Turkey). Clinical characteristics and outcome of patients with Behçet’s Disease and thrombosis. 3129

Member's Comments

No comment yet.

Related content which might interest you: Clinical characteristics of elderly patients with pulmonary embolism and risk factors for recurrence Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside Year: 2016 Clinical characteristics and prognostic factors of pulmonary embolism in different age groups Source: Annual Congress 2013 –Pulmonary circulation: acute pulmonary tromboembolism Year: 2013 Disease characteristics and outcomes in a Swedish cohort of patients with pulmonary fibrosis (PF) Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs) Year: 2018 Clinical features and outcome of COVID-19 pneumonia in haemodialysis patients Source: Virtual Congress 2021 – Diagnosis and management of COVID-19 Year: 2021 10 years’ experience of referral of ILD patients with Suspected PH to a National PH Service: Demographics and Outcomes Source: International Congress 2018 – Pulmonary hypertension in lung diseases and the role of the right ventricle Year: 2018 Liver dysfunction on admission worsen clinical manifestations and outcomes of Coronavirus Disease 2019 Source: Virtual Congress 2021 – COVID - 19 risk predictions Year: 2021 Clinical characteristics and outcome of patients with empyema and hepatic cirrhosis Source: Annual Congress 2010 - Unusual pathogens in respiratory infections Year: 2010 Clinical and prognostic scores in patients with cancer and pulmonary embolism Source: International Congress 2016 – Acute pulmonary embolism Year: 2016 Clinical characteristics and outcomes in hospitalized COVID-19 patients with COPD Source: Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects Year: 2021 Disease progression at 12 months does not predict future outcomes in IPF patients: Analysis from the Australian IPF Registry Source: International Congress 2017 – ILDs: clinical aspects Year: 2017 Acute Pulmonary Embolism in COPD patients, clinical features and outcomes Source: International Congress 2017 – Pulmonary embolism Year: 2017 The presentation and outcome of chronic pulmonary lobar collapse in children Source: International Congress 2014 – Neonatal and paediatric intensive care Year: 2014 Disease awareness in COPD: Analyses of clinical parameters and patient-reported outcome from the SAT study Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more Year: 2020 Anti-synthetase syndrome associated Interstitial Lung Disease (ASS-ILD): clinical heterogeneity and outcome Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017 GRACE scores in COPD patients with acute coronary syndromes: Performance and impact on secondary prevention Source: International Congress 2015 – COPD and lung function: risk factors and outcomes Year: 2015 Prognostic value of outcome variables at follow-up in patients with PAH Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension Year: 2014 Pulmonary amyloidosis: Clinical features in a series of twelve patients Source: Annual Congress 2010 - Rare diffuse lung diseases Year: 2010 Clinical profile and mortality of patients with pulmonary embolism and cancer Source: International Congress 2015 – Pulmonary circulation: the story of fresh and old clots Year: 2015 The Bronchiectasis Research Registry: Clinical, microbiologic, and treatment characteristics Source: Annual Congress 2010 - COPD: diagnosis Year: 2010